{'52WeekChange': -0.17777783,
 'SandP52WeekChange': 0.0644362,
 'address1': '5770 Armada Drive',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 10.33,
 'askSize': 3000,
 'averageDailyVolume10Day': 65187,
 'averageVolume': 129693,
 'averageVolume10days': 65187,
 'beta': 0.896358,
 'beta3Year': None,
 'bid': 10.28,
 'bidSize': 1300,
 'bookValue': 6.971,
 'category': None,
 'circulatingSupply': None,
 'city': 'Carlsbad',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 10.39,
 'dayLow': 9.97,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -6.991,
 'enterpriseToRevenue': 1.176,
 'enterpriseValue': 187101616,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 10.541429,
 'fiftyTwoWeekHigh': 16.78,
 'fiftyTwoWeekLow': 4.02,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 21972346,
 'forwardEps': -1.09,
 'forwardPE': -9.504586,
 'fromCurrency': None,
 'fullTimeEmployees': 386,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.12582,
 'heldPercentInstitutions': 0.63843,
 'industry': 'Medical Devices',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/seaspine.com',
 'longBusinessSummary': 'SeaSpine Holdings Corporation, a medical technology '
                        'company, focuses on the design, development, and '
                        'commercialization of surgical solutions for the '
                        'treatment of spinal disorders in the United States '
                        'and internationally. The company provides '
                        'orthobiologics and spinal implant solutions for the '
                        'neurosurgeons and orthopedic spine surgeons to '
                        'perform fusion procedures in the lumbar, thoracic, '
                        'and cervical spine. Its orthobiologics products '
                        'include demineralized bone matrices (DBM), collagen '
                        'ceramic matrices, demineralized cancellous allograft '
                        'bone products, and synthetic bone void fillers to '
                        'improve bone fusion rates in a range of orthopedic '
                        'surgeries, including spine, hip, and extremities '
                        'procedures. The company also offers orthobiologics '
                        'products in various forms, such as fibers, putties, '
                        'pastes, strips, and DBM. Its spinal implant portfolio '
                        'comprises products for spinal decompression, '
                        'alignment, and stabilization that are used to '
                        'facilitate fusion in degenerative, minimally '
                        'invasive, and complex spinal deformity procedures '
                        'throughout the lumbar, thoracic, and cervical regions '
                        'of the spine. The company has development and '
                        'licensing agreement with restor3d, Inc. to develop '
                        '3D-printed interbody devices. SeaSpine Holdings '
                        'Corporation was incorporated in 2015 and is '
                        'headquartered in Carlsbad, California.',
 'longName': 'SeaSpine Holdings Corporation',
 'market': 'us_market',
 'marketCap': 282248864,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_275882336',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -42838000,
 'nextFiscalYearEnd': 1640908800,
 'open': 10.27,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '760 727 8399',
 'previousClose': 10.27,
 'priceHint': 2,
 'priceToBook': 1.4861568,
 'priceToSalesTrailing12Months': 1.774659,
 'profitMargins': -0.26935,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 10.39,
 'regularMarketDayLow': 9.97,
 'regularMarketOpen': 10.27,
 'regularMarketPreviousClose': 10.27,
 'regularMarketPrice': 10.27,
 'regularMarketVolume': 75318,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 27244100,
 'sharesPercentSharesOut': 0.028800001,
 'sharesShort': 783384,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 606577,
 'shortName': 'SeaSpine Holdings Corporation',
 'shortPercentOfFloat': 0.0364,
 'shortRatio': 4.53,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'SPNE',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -2.053,
 'twoHundredDayAverage': 11.456979,
 'volume': 75318,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.seaspine.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '92008'}